TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer

Acta Biochimica Et Biophysica Sinica
Beili ZhangYan Gu

Abstract

Gastric cancer is one of the most common cancers worldwide and is the third leading cause of cancer-related deaths globally. Although significant progress has been made in the diagnosis and treatment for the cancer, less improvement has been made in overall survival rate. Thus, there is an urgent need for a better understanding of the biological aspects of the cancer. The transcription factor transcription factor 7-like 1 (TCF7L1) is an embryonic stem cell signature gene that is upregulated in multiple aggressive cancer types, but its role in gastric cancer has seldom been discussed. In the present study, by using the Cancer Genome Atlas dataset analysis, we demonstrated that patients with higher expression of TCF7L1 could be used to reflect prognosis. An examination of the mechanisms demonstrated that TCF7L1 could positively regulate antioxidant response in gastric cancer cells by positively regulating Keap1/NRF2 [Kelch-like ECH-associated protein 1/nuclear factor (erythroid-derived 2)-like 2] pathway. Collectively, our data demonstrated that TCF7L1 is a novel marker for predicting overall survival of gastric cancer and provided the possible underlying molecular mechanism.

References

Jan 15, 2009·Nature Reviews. Cancer·Nicholas C Denko
May 26, 2011·Epigenetics : Official Journal of the DNA Methylation Society·Lucia Anna MuscarellaVito Michele Fazio
Jan 13, 2012·Cell Death & Disease·C Muñoz-PinedoJ-E Ricci
Feb 14, 2012·BMC Cancer·Naoyuki HanadaYasuo Saijo
Feb 22, 2012·Histopathology·Nam Jin YooSug Hyung Lee
Jul 14, 2012·Cancer Cell·Yoichiro MitsuishiHozumi Motohashi
Jul 20, 2012·Nature Reviews. Cancer·Michael B Sporn, Karen T Liby
Dec 20, 2012·Epigenetics : Official Journal of the DNA Methylation Society·Raffaela BarbanoPaola Parrella
Sep 26, 2013·Nature Reviews. Cancer·Benjamin Beck, Cédric Blanpain
Mar 4, 2014·World Journal of Gastroenterology : WJG·Michele OrdituraFerdinando De Vita
May 16, 2014·The EMBO Journal·Kira T PateMarian L Waterman
Aug 20, 2014·Nature Reviews. Gastroenterology & Hepatology·Mairi H McLean, Emad M El-Omar
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Oct 23, 2014·Antioxidants & Redox Signaling·Patricia RadaAntonio Cuadrado
Jan 16, 2015·Journal of Carcinogenesis·Lauren Peirce Carcas
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
May 21, 2015·World Journal of Experimental Medicine·Miguel Angel Chiurillo
Dec 18, 2015·The EMBO Journal·Gillian MorrisonAustin Smith
Mar 17, 2016·Current Molecular Medicine·B ZhangX Yu
Apr 30, 2017·Biochemical and Biophysical Research Communications·Melanie A EshelmanGregory S Yochum
Oct 11, 2017·Expert Opinion on Therapeutic Targets·Wanli YangLiu Hong
Dec 25, 2017·The International Journal of Biochemistry & Cell Biology·Hong-Sheng ZhangYing-Hui Huang
Jan 3, 2018·Seminars in Cancer Biology·Angela PoffNagi B Kumar

❮ Previous
Next ❯

Citations

Aug 24, 2019·Cancers·Christopher M R LangWen-Hui Lien
Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tahereh FarkhondehSaeed Samarghandian

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
PCR
Protein Assay
Assay
ChIP
RNA-seq

Software Mentioned

SPSS
STAD

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.